Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Canepa-Anson

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
British Journal of Clinical Pharmacology|February 1, 1987
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failureR Canepa-Anson, J R Dawson, P Kuan, et al.
European Heart Journal|December 1, 1982
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmiasR Canepa-Anson, J R Dawson, W S Frankl, et al.
American Heart Journal|September 1, 1981
Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failureR Canepa-Anson, J R Dawson, P Kuan, et al.
The American Journal of Physiology|July 1, 1989
Atrial natriuretic peptide response to rapid atrial pacing in cardiac-denervated dogsT D Williams, K P Walsh, R Canepa-Anson, et al.
European Heart Journal|December 1, 1982
Clinical studies with beta 2 adrenoceptor agonists in heart failureJ R Dawson, J Bayliss, M S Norell, et al.
British Medical Journal (Clinical Research Ed.)|May 2, 1981
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responsesJ R Dawson, R Canepa-Anson, P Kuan, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
British Journal of Clinical Pharmacology|February 1, 1987
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failureR Canepa-Anson, J R Dawson, P Kuan, et al.
European Heart Journal|December 1, 1982
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmiasR Canepa-Anson, J R Dawson, W S Frankl, et al.
American Heart Journal|September 1, 1981
Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failureR Canepa-Anson, J R Dawson, P Kuan, et al.
The American Journal of Physiology|July 1, 1989
Atrial natriuretic peptide response to rapid atrial pacing in cardiac-denervated dogsT D Williams, K P Walsh, R Canepa-Anson, et al.
European Heart Journal|December 1, 1982
Clinical studies with beta 2 adrenoceptor agonists in heart failureJ R Dawson, J Bayliss, M S Norell, et al.
British Medical Journal (Clinical Research Ed.)|May 2, 1981
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responsesJ R Dawson, R Canepa-Anson, P Kuan, et al.
Pageof 4